Adial Pharmaceuticals Announces Partnership with 探花合集 for Adial鈥檚 AD04
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced a partnership with 探花合集 to advance clinical activities related to AD04, Adial鈥檚 genetically targeted, lead investigational new drug product for the treatment of alcohol use disorder. This partnership brings together critical capabilities to allow the commencement of Adial鈥檚 planned initial Phase 3 trial, with 探花合集 providing clinical packaging and distribution.